Nkarta (NKTX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Voting matters and shareholder proposals
Election of three directors to serve until the 2028 annual meeting, with board recommending all nominees.
Ratification of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2025.
Proxies authorized to vote on other business that may arise at the meeting or any adjournment.
Board of directors and corporate governance
Director nominees include Michael Dybbs, Ph.D., Simeon George, M.D., M.B.A., and Leone Patterson, M.B.A.
Directors to serve until 2028 or until successors are elected and qualified.
Audit committee and external auditor matters
Ernst & Young LLP proposed for ratification as independent auditor for the 2025 fiscal year.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Nkarta
- Focused on CD19 NK cell therapy for autoimmune disease, advancing toward pivotal trials and outpatient care.NKTX
Leerink Global Healthcare Conference 202610 Mar 2026 - Allogeneic NK cell therapy advances with strong safety, pivotal data expected this year.NKTX
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Allogeneic CAR NK therapy advances in autoimmune diseases, with key data expected in 2025.NKTX
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026 - Leading allogeneic NK cell trials in autoimmune disease, prioritizing safety and drug-free remission.NKTX
Stifel 2024 Healthcare Conference13 Jan 2026 - Robust, safe, off-the-shelf NK cell therapy targets I&I with key data expected in 2025.NKTX
7th Annual Evercore ISI HealthCONx Healthcare Conference11 Jan 2026 - Allogeneic CAR-NK cells show promise for safe, flexible autoimmune therapy with broad potential.NKTX
TD Cowen 45th Annual Healthcare Conference26 Dec 2025 - Allogeneic CAR-NK therapies show strong safety and scalability for autoimmune diseases, with key data ahead.NKTX
24th Annual Needham Virtual Healthcare Conference23 Dec 2025 - Robust I&I data expected next year, with accelerated enrollment and strong financial runway.NKTX
Evercore ISI 8th Annual HealthCONx Conference7 Dec 2025 - Annual meeting to elect directors, ratify auditor, and review governance, compensation, and oversight.NKTX
Proxy Filing2 Dec 2025